Follow
Kalliopi Foteinogiannopoulou
Kalliopi Foteinogiannopoulou
University Hospital of Heraklion
Verified email at med.uoc.gr
Title
Cited by
Cited by
Year
Inflammatory bowel disease [IBD] and physical activity: a study on the impact of diagnosis on the level of exercise amongst patients with IBD
K Gatt, J Schembri, KH Katsanos, D Christodoulou, K Karmiris, U Kopylov, ...
Journal of Crohn's and Colitis 13 (6), 686-692, 2019
552019
Endoscopic postoperative recurrence in Crohn’s disease after curative ileocecal resection with early prophylaxis by anti-TNF, vedolizumab or ustekinumab: a real-world …
H Yanai, A Kagramanova, O Knyazev, J Sabino, S Haenen, GJ Mantzaris, ...
Journal of Crohn's and Colitis 16 (12), 1882-1892, 2022
312022
Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab
E Orfanoudaki, M Gazouli, K Foteinogiannopoulou, E Theodoraki, ...
European Journal of Gastroenterology & Hepatology 31 (2), 187-191, 2019
132019
Effectiveness of third-class biologic treatment in Crohn’s disease: a multi-center retrospective cohort study
A Albshesh, J Taylor, EV Savarino, M Truyens, A Armuzzi, DG Ribaldone, ...
Journal of clinical medicine 10 (13), 2914, 2021
122021
Mental health, work presenteeism, and exercise in inflammatory bowel disease
M Sciberras, K Karmiris, C Nascimento, T Tabone, P Nikolaou, ...
Journal of Crohn's and Colitis 16 (8), 1197-1201, 2022
102022
The burden and management of anemia in Greek patients with inflammatory bowel disease: A retrospective, multicenter, observational study
K Foteinogiannopoulou, K Karmiris, G Axiaris, M Velegraki, A Gklavas, ...
BMC gastroenterology 21, 1-10, 2021
92021
Asymptomatic hyperCKemia during infliximab therapy in patients with inflammatory bowel disease
E Theodoraki, E Orfanoudaki, K Foteinogiannopoulou, IE Koutroubakis
Inflammatory Bowel Diseases 24 (6), 1266-1271, 2018
82018
Use of vedolizumab in a patient with chronic and refractory pouchitis
E Orfanoudaki, K Foteinogiannopoulou, IE Koutroubakis
Annals of Gastroenterology 31 (3), 379, 2018
82018
Solid extraintestinal malignancies in patients with inflammatory bowel disease
A Mala, K Foteinogiannopoulou, IE Koutroubakis
World Journal of Gastrointestinal Oncology 13 (12), 1956, 2021
72021
Keeping on the high quality of health care in Greek inflammatory bowel disease patients in the SARS-CoV-2 era
K Foteinogiannopoulou, E Orfanoudaki, IE Koutroubakis
Clinical Gastroenterology and Hepatology 18 (10), 2380-2381, 2020
72020
Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
E Theodoraki, E Orfanoudaki, K Foteinogiannopoulou, E Legaki, ...
Intestinal research 19 (4), 461, 2021
62021
Gastroenteropancreatic neuroendocrine neoplasms in patients with inflammatory bowel disease: an ECCO CONFER multicentre case series
S Festa, G Zerboni, LAAP Derikx, DG Ribaldone, G Dragoni, C Buskens, ...
Journal of Crohn's and Colitis 16 (6), 940-945, 2022
52022
Recent advances in the optimization of anti-TNF treatment in patients with inflammatory bowel disease
E Orfanoudaki, K Foteinogiannopoulou, E Theodoraki, IE Koutroubakis
Journal of Clinical Medicine 12 (7), 2452, 2023
32023
First case of Whipple’s disease successfully treated with tigecycline
K Foteinogiannopoulou, I Mouzas, M Tzardi, E Orfanoudaki, E Theodoraki, ...
Germs 11 (1), 105, 2021
32021
Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under …
E Orfanoudaki, I Drygiannakis, E Theodoraki, K Foteinogiannopoulou, ...
European Journal of Gastroenterology & Hepatology 33 (1S), e777-e782, 2021
22021
Mucocutaneous manifestations in patients with inflammatory bowel disease: a decade study from a Greek cohort
D Koumaki, A Machaira, AC Katoulis, P Bitados, E Orfanoudaki, ...
European Journal of Gastroenterology & Hepatology 33 (11), 1387-1393, 2021
22021
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD
S Vieujean, JO Lindsay, F D’Amico, V Ahuja, MS Silverberg, A Sood, ...
Journal of Crohn's and Colitis 18 (4), 548-559, 2024
12024
Comparison between tofacitinib and ustekinumab as a third‐line therapy in refractory ulcerative colitis: A multicenter international study
M Allocca, G Catalano, EV Savarino, M Chaparro, A Levartovsky, ...
United European Gastroenterology Journal, 2024
12024
Active smoking is associated with the development of adverse events of biological therapy in patients with inflammatory bowel disease
E Theodoraki, E Orfanoudaki, E Petroulaki, K Foteinogiannopoulou, ...
European Journal of Gastroenterology & Hepatology 35 (1), 15-20, 2023
12023
Infliximab trough levels are decreasing overtime in patients with inflammatory bowel disease on maintenance treatment with infliximab
E Orfanoudaki, M Gazouli, K Foteinogiannopoulou, E Theodouraki, ...
JOURNAL OF CROHNS & COLITIS 12, S330-S331, 2018
12018
The system can't perform the operation now. Try again later.
Articles 1–20